The authors also showed functional differences between NK cells derived from PTLD patients compared to healthy controls (decreased CD107a, IFNγ), with augmentation of NK function in PTLD patients when they were treated with anti-PD-1 in vitro. This evidence concerns the gene IFNG and post-transplant lymphoproliferative disease.